User contributions for UmaMaveli
Jump to navigation
Jump to search
9 October 2020
- 20:0720:07, 9 October 2020 diff hist +19,309 Revefenacin No edit summary
- 17:2417:24, 9 October 2020 diff hist +592 Revefenacin No edit summary
- 17:2217:22, 9 October 2020 diff hist +2 Revefenacin →Carcinogenesis, Mutagenesis, Impairment of Fertility
- 17:1317:13, 9 October 2020 diff hist +26 Revefenacin No edit summary Tag: Visual edit
- 17:0317:03, 9 October 2020 diff hist −1,189 Revefenacin →Overdose
- 17:0217:02, 9 October 2020 diff hist −10 Revefenacin →Use in Specific Populations
- 17:0017:00, 9 October 2020 diff hist +291 Revefenacin No edit summary
- 16:5816:58, 9 October 2020 diff hist −2,238 Revefenacin →Serious Meningococcal Infections
- 16:5716:57, 9 October 2020 diff hist 0 Revefenacin →overdose
- 16:5716:57, 9 October 2020 diff hist −1 Revefenacin →Clinical Studies
- 16:5716:57, 9 October 2020 diff hist +1 Revefenacin →brandNames
- 16:5616:56, 9 October 2020 diff hist 0 Revefenacin →Clinical Studies
- 16:5516:55, 9 October 2020 diff hist −1 Revefenacin →Dosage
- 16:5216:52, 9 October 2020 diff hist −5,068 Revefenacin →Clinical Studies
- 16:5016:50, 9 October 2020 diff hist 0 N File:Patient Demographics.jpg No edit summary current
- 16:4616:46, 9 October 2020 diff hist +8 Revefenacin →Infusion reactions
- 16:4616:46, 9 October 2020 diff hist −154 Revefenacin →Infusion reactions
- 16:4516:45, 9 October 2020 diff hist +1 Revefenacin →clinicalStudies
- 16:4416:44, 9 October 2020 diff hist −1 Revefenacin →Meningococcal Infection
- 16:4316:43, 9 October 2020 diff hist −3,145 Revefenacin →Clinical Studies
- 16:4116:41, 9 October 2020 diff hist −76 Revefenacin →Specific Populations
- 16:4016:40, 9 October 2020 diff hist −1,980 Revefenacin →Infusion Reactions
- 16:3916:39, 9 October 2020 diff hist −174 Revefenacin →Administration of Revefenacin
- 16:3716:37, 9 October 2020 diff hist −248 Revefenacin →Dosage
- 16:3316:33, 9 October 2020 diff hist −238 Revefenacin →Recommended Vaccination and Prophylaxis
- 16:3316:33, 9 October 2020 diff hist +171 Revefenacin →Limitations of Use
- 16:2916:29, 9 October 2020 diff hist +55 Revefenacin →ULTOMIRIS is indicated for:
- 16:2416:24, 9 October 2020 diff hist −1,271 Revefenacin →Preparation of ULTOMIRIS
- 16:2316:23, 9 October 2020 diff hist −33 Revefenacin →drugShortage
- 16:2316:23, 9 October 2020 diff hist −986 Revefenacin →Dosage
- 16:1216:12, 9 October 2020 diff hist −1,844 Revefenacin →Monitoring Disease Manifestations after ULTOMIRIS Discontinuation
- 16:1116:11, 9 October 2020 diff hist 0 Revefenacin →Infusion reactions
- 16:0716:07, 9 October 2020 diff hist −1,716 Revefenacin No edit summary
- 16:0116:01, 9 October 2020 diff hist +23,346 Revefenacin No edit summary
- 04:3204:32, 9 October 2020 diff hist −1,104 Revefenacin No edit summary
- 04:3204:32, 9 October 2020 diff hist +8 Revefenacin No edit summary
- 04:3104:31, 9 October 2020 diff hist +1,097 Revefenacin No edit summary
- 04:2704:27, 9 October 2020 diff hist +579 Revefenacin →Overview
8 October 2020
- 04:1704:17, 8 October 2020 diff hist +22 Revefenacin →Warnings
- 04:1604:16, 8 October 2020 diff hist −22 Revefenacin →Adult Indications and Dosage
- 04:1604:16, 8 October 2020 diff hist −38 Revefenacin →Pediatric Indications and Dosage
- 04:1604:16, 8 October 2020 diff hist +294 Revefenacin →Use in Specific Populations
- 04:1104:11, 8 October 2020 diff hist +136 Revefenacin →Drug Interactions
- 04:0804:08, 8 October 2020 diff hist +53 Revefenacin →Contradictions
- 04:0704:07, 8 October 2020 diff hist +148 Revefenacin →Precautions with Alcohol
- 04:0604:06, 8 October 2020 diff hist +77 Revefenacin →Patient Counseling Information
- 04:0204:02, 8 October 2020 diff hist +566 Revefenacin →Clinical Studies
- 03:5203:52, 8 October 2020 diff hist +1 Revefenacin →Pharmacology
- 03:5203:52, 8 October 2020 diff hist +20 Revefenacin →Pharmacology
- 03:4803:48, 8 October 2020 diff hist −13 Gilteritinib →Warnings